✦ LIBER ✦

Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma

✍ Scribed by Giovan Giuseppe Di Costanzo, Raffaella Tortora, Massimo De Luca, Alfonso Galeota Lanza, Filippo Lampasi, Maria Teresa Tartaglione, Francesco Paolo Picciotto, Michele Imparato, Silvana Mattera, Gabriella Cordone, Antonio Ascione

Book ID: 118821814
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 237 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-012-0446-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exposure–Toxicity Relationship of Sorafe

Exposure–Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma

✍ Fukudo, Masahide; Ito, Takuma; Mizuno, Tomoyuki; Shinsako, Keiko; Hatano, Etsuro 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 508 KB

Efficacy and safety of sorafenib in very

Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma

✍ Jo, Masayasu; Yasui, Kohichiroh; Kirishima, Toshihiko; Shima, Toshihide; Niimi, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

629 SAFETY AND EFFECTIVENESS OF TREATMEN

629 SAFETY AND EFFECTIVENESS OF TREATMENT WITH SORAFENIB IN ELDERLY CIRRHOTIC PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA

✍ R. Tortora; A. Galeota Lanza; F. Lampasi; M. De Luca; M.T. Tartaglione; R. Pacil 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 78 KB

250 RELATIONSHIP BETWEEN PLASMA CONCENTR

250 RELATIONSHIP BETWEEN PLASMA CONCENTRATION AND DAILY DOSE OF SORAFENIB IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)

✍ Bazzica, M.; Fucile, C.; Mattioli, F.; Marenco, S.; Lantieri, F.; Savarino, V.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Phase 2 Study of Combined Sorafenib and

Phase 2 Study of Combined Sorafenib and Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma

✍ Chen, Shang-Wen; Lin, Li-Ching; Kuo, Yu-Cheng; Liang, Ji-An; Kuo, Chia-Chun; Chi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

✍ Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 934 KB